Posted in | News | Lighting | Display

Universal Display Receives SBIR Phase II Contract to Advance Thin-Film Encapsulation Technology

Universal Display Corporation (NASDAQ: PANL), enabling energy-efficient displays and lighting with its UniversalPHOLED™ technology and materials, today announced that the company has been awarded a $ 499,999 Small Business Innovation Research (SBIR) Phase II contract from the National Science Foundation (NSF) to demonstrate further advances in its novel thin-film encapsulation technology.

Universal Display is focused on the technology’s use as a cost-effective, protective barrier for flexible OLED displays and lighting. The company’s thin-film encapsulation technology also has applicability to a variety of other thin-film electronics including solar cells, batteries, sensors and photodectors.

In the Phase II program, Universal Display will focus on demonstrating that its environmentally-friendly, single-layer approach exhibits manufacturing scalability and prospective cost effectiveness. This program follows a successful Phase I program during which the Company, working with Princeton University, demonstrated that this approach has the performance characteristics to be an ultra-hermetic, transparent and flexible permeation barrier that can provide OLEDs with the long-term operational stability for a variety of demanding conditions.

“We are very pleased to have the opportunity to continue our work with the National Science Foundation to demonstrate the commercial potential of our novel encapsulation technology,” says Steven V. Abramson, President and Chief Executive Officer of Universal Display. “Encapsulation technology that is both high-performance and cost-effective is well recognized as a critical element to the commercialization of flexible OLED displays and lighting. This environmentally-friendly, single-layer approach also has the potential to provide value to a wide variety of other flexible and rigid, thin-film electronic applications.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.